--- title: Brookfield (BN) — stock overview: intrinsic value, grades and financials canonical: https://sweetvaluelab.com/stocks/bn ticker: BN as_of: 2026-11-02 sector: Financial Services industry: Asset Management --- # Brookfield (BN) Brookfield (BN) closed at $39.28 on Oct 30, 2026, overvalued by 20% vs model: P/E · peers puts it at $32.66 a share. The other 3 models range from $2.59 to $113.63, and the median analyst target is $56.50 from 6 firms. In Q2 FY2026, the latest quarter on file, revenue grew 7% on a year earlier to $19.3B, with a net margin of 1.8%. Over the twelve months to Q2 FY2026, net income was $1.4B. Among the superinvestors tracked here, Dodge & Cox added and Ackman reduced. The latest filing is a 6-K (current report (foreign issuer)), filed Oct 22. The valuation in full, model by model: https://sweetvaluelab.com/stocks/bn/valuation. ## Key figures | Figure | Value | | --- | ---: | | Last close | $39.28 (Oct 30, 2026) | | Model value (from its peers' median P/E) | $32.66 | | Price vs model | overvalued by 20% vs model | | Range of that model | $25.72 – $45.36 | | Market value | $87.7B | | P/E (fiscal 2025) | 78.6 | | Net margin (fiscal 2025) | 1.7% | | Free cash flow (fiscal 2025) | $0 | | Dividend yield (trailing twelve months) | 0.69% | | Beta | 1.84 | | Cost of capital (WACC) | 5.66% | | Business classification | Mature & Stable (Revenue declining (~-11% recent), Thin margins (1.7% net margin), Highly cyclical earnings, High leverage (D/E 6.5x)) | ## The last eight quarters | Quarter | Revenue | Change on a year earlier | Net margin | | --- | ---: | ---: | ---: | | Q3 FY2024 | $20.6B | — | 0.3% | | Q4 FY2024 | $19.4B | — | 2.2% | | Q1 FY2025 | $17.9B | — | 0.4% | | Q2 FY2025 | $18.1B | — | 1.5% | | Q3 FY2025 | $18.9B | −8.3% | 1.2% | | Q4 FY2025 | $21.2B | +9.0% | 3.5% | | Q1 FY2026 | $18.4B | +2.5% | 0.5% | | Q2 FY2026 | $19.3B | +6.6% | 1.8% | Twelve months to Q2 FY2026, against the twelve before: | Line | Latest | Year before | | --- | ---: | ---: | | Revenue | $77.8B | $76.1B | | Net income | $1.4B | $841.0M | | Diluted EPS | $0.57 | $0.30 | ## Dividends | Figure | Value | | --- | ---: | | Trailing dividend yield | 0.69% | | Dividends per share, last 12 months | $0.27 | | Coverage | — | | Raised | 2 years in a row | | Growth over 5 years | −0.2% a year | | Latest payment | $0.07, ex-date Sep 14, 2026, paid Sep 29, 2026 | | Year of payments | Dividends per share | | --- | ---: | | To Aug 30, 2021 | $0.27 | | To Aug 30, 2022 | $0.30 | | To Aug 30, 2023 | $0.22 | | To Sep 12, 2024 | $0.21 | | To Sep 12, 2025 | $0.23 | | Trailing twelve months (to Sep 14, 2026) | $0.27 | ## Valuation models Each model's value per share and the role the engine gave it for this business. The headline above is one model's value; every other model is listed with its own, and each has a page of its own under the valuation. Computed Nov 2, 2026. | Model | Role | Value per share | Low | High | | --- | --- | ---: | ---: | ---: | | P/E · peers | primary | $32.66 | $25.72 | $45.36 | | P/E · own history | cross check | $113.63 | $42.91 | $152.10 | | PEG | sanity check | $4.00 | $4.00 | $4.00 | | Dividend discount | cross check | $2.59 | $2.10 | $3.69 | ## Wall Street analysts The median of each covering firm's latest price target is $56.50, from 6 firms — the analysts' figure, quoted, and not part of the model value above. Each firm's latest target, the current grades, the grade changes and the consensus revenue and EPS estimates: https://sweetvaluelab.com/stocks/bn/analysts (Markdown: https://sweetvaluelab.com/stocks/bn/analysts.md). ## Insider activity (SEC Form 4) No open-market insider buys or sales filed in the past 90 days. ## Recent SEC filings | Filed | Form | What | Filing | | --- | --- | --- | --- | | Oct 22, 2026 | 6-K | Current report (foreign issuer) | https://www.sec.gov/Archives/edgar/data/1001085/000110465926118154/tm2628103d1_6k.htm | | Oct 16, 2026 | 6-K | Current report (foreign issuer) | https://www.sec.gov/Archives/edgar/data/1001085/000110465926116314/tm2627665d1_6k.htm | | Oct 9, 2026 | 6-K | Current report (foreign issuer) | https://www.sec.gov/Archives/edgar/data/1001085/000117184326006563/f6k_100926.htm | | Sep 23, 2026 | 6-K | Current report (foreign issuer) | https://www.sec.gov/Archives/edgar/data/1001085/000110465926110024/tm2625808d7_6k.htm | | Sep 23, 2026 | 6-K | Current report (foreign issuer) | https://www.sec.gov/Archives/edgar/data/1001085/000110465926109720/tm2625808d6_6k.htm | ## Superinvestors holding it (latest 13F) | Manager | Quarter | Shares | Value | | --- | --- | ---: | ---: | | Dodge & Cox | 2026-06-30 | 61,210,651 | $2.6B | | Ackman | 2026-06-30 | 57,481,047 | $2.4B | | Akre | 2026-06-30 | 12,119,927 | $516.2M | | Thomas Gayner | 2026-09-30 | 13,073,609 | $476.7M | 8 tracked managers in all. ## About Brookfield Corporation operates as a leading alternative asset and real estate investment management firm. It specializes in real estate, renewable power, infrastructure, venture capital, and private equity, providing a diverse range of public and private investment products and services to institutional and individual clients alike. The firm's investment approach centers on acquiring substantial, high-quality assets worldwide, utilizing both its proprietary capital and funds contributed by other investors. Within its private equity and venture capital divisions, Brookfield engages in a broad spectrum of activities, including growth equity, early-stage investments, control and distressed buyouts, corporate spin-offs, recapitalizations, and various forms of debt financing (convertible, senior, and mezzanine). It also focuses on operational and capital structure restructuring, strategic tu… --- Source: https://sweetvaluelab.com/stocks/bn (SweetValueLab, free, no account). Prices and statements from Financial Modeling Prep; filings from SEC EDGAR. Research and educational data, not investment advice; nothing here is a recommendation to buy, sell or hold any security.